Spirepoint Private Client LLC lessened its stake in shares of Ingredion Incorporated (NYSE:INGR - Free Report) by 93.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,429 shares of the company's stock after selling 34,534 shares during the quarter. Spirepoint Private Client LLC's holdings in Ingredion were worth $268,000 at the end of the most recent quarter.
Several other large investors have also modified their holdings of the stock. Dimensional Fund Advisors LP raised its stake in shares of Ingredion by 4.3% during the third quarter. Dimensional Fund Advisors LP now owns 2,762,402 shares of the company's stock worth $337,311,000 after purchasing an additional 114,521 shares during the last quarter. Massachusetts Financial Services Co. MA raised its stake in shares of Ingredion by 2.2% during the third quarter. Massachusetts Financial Services Co. MA now owns 1,369,448 shares of the company's stock worth $167,223,000 after purchasing an additional 29,433 shares during the last quarter. Snyder Capital Management L P raised its stake in shares of Ingredion by 22.0% during the third quarter. Snyder Capital Management L P now owns 1,323,847 shares of the company's stock worth $161,655,000 after purchasing an additional 238,420 shares during the last quarter. AQR Capital Management LLC raised its stake in shares of Ingredion by 143.1% during the third quarter. AQR Capital Management LLC now owns 1,191,118 shares of the company's stock worth $144,685,000 after purchasing an additional 701,063 shares during the last quarter. Finally, First Trust Advisors LP raised its stake in shares of Ingredion by 6.3% during the third quarter. First Trust Advisors LP now owns 1,044,819 shares of the company's stock worth $127,583,000 after purchasing an additional 62,115 shares during the last quarter. Hedge funds and other institutional investors own 85.27% of the company's stock.
Insider Activity
In other news, VP Davida Marie Gable sold 375 shares of the firm's stock in a transaction on Wednesday, March 18th. The stock was sold at an average price of $112.44, for a total value of $42,165.00. Following the completion of the transaction, the vice president owned 7,110 shares in the company, valued at $799,448.40. This trade represents a 5.01% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO James P. Zallie sold 33,597 shares of the firm's stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $119.66, for a total value of $4,020,217.02. Following the completion of the transaction, the chief executive officer owned 50,167 shares of the company's stock, valued at approximately $6,002,983.22. This represents a 40.11% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 48,686 shares of company stock worth $5,784,010 over the last 90 days. 2.30% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Several equities research analysts have recently commented on the company. Weiss Ratings restated a "hold (c)" rating on shares of Ingredion in a research note on Friday, March 27th. Stephens restated an "equal weight" rating and set a $120.00 price target on shares of Ingredion in a research note on Wednesday, February 4th. Jefferies Financial Group reiterated a "hold" rating on shares of Ingredion in a research report on Wednesday, February 4th. Barclays increased their price objective on Ingredion from $124.00 to $128.00 and gave the stock an "equal weight" rating in a research report on Wednesday, February 4th. Finally, UBS Group cut their price objective on Ingredion from $124.00 to $122.00 and set a "neutral" rating for the company in a research report on Thursday. Two analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, Ingredion currently has an average rating of "Hold" and a consensus price target of $126.14.
Get Our Latest Analysis on Ingredion
Ingredion Trading Down 0.1%
NYSE:INGR opened at $114.78 on Friday. The stock has a fifty day moving average price of $114.77 and a two-hundred day moving average price of $114.04. The stock has a market capitalization of $7.22 billion, a price-to-earnings ratio of 10.28, a PEG ratio of 0.91 and a beta of 0.70. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.73 and a current ratio of 2.66. Ingredion Incorporated has a 1 year low of $102.31 and a 1 year high of $141.78.
Ingredion (NYSE:INGR - Get Free Report) last released its quarterly earnings data on Tuesday, February 3rd. The company reported $2.53 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.59 by ($0.06). The business had revenue of $1.76 billion during the quarter, compared to analysts' expectations of $1.78 billion. Ingredion had a return on equity of 17.32% and a net margin of 10.10%.The company's revenue was down 2.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.63 EPS. Ingredion has set its FY 2026 guidance at 11.000-11.8 EPS. As a group, sell-side analysts anticipate that Ingredion Incorporated will post 11.14 earnings per share for the current fiscal year.
Ingredion Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 21st. Stockholders of record on Wednesday, April 1st will be given a $0.82 dividend. The ex-dividend date is Wednesday, April 1st. This represents a $3.28 dividend on an annualized basis and a dividend yield of 2.9%. Ingredion's dividend payout ratio (DPR) is currently 29.39%.
About Ingredion
(
Free Report)
Ingredion Incorporated is a global ingredient solutions company specializing in the production and sale of starches, sweeteners, nutrition ingredients and biomaterials derived primarily from corn and other plant-based raw materials. The company serves a diverse set of industries, including food and beverage, brewing, pharmaceuticals and personal care, providing functional ingredients that enhance texture, stability, flavor and nutritional value in a wide array of end products.
The company's product portfolio comprises native and modified starches, high-fructose corn syrup, dextrose, maltodextrins, specialty sweeteners and various texturizers.
Read More
Want to see what other hedge funds are holding INGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingredion Incorporated (NYSE:INGR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ingredion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ingredion wasn't on the list.
While Ingredion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report